HEADER TRANSFERASE/INHIBITOR 07-DEC-11 3V04 TITLE DISCOVERY OF NOVEL ALLOSTERIC MEK INHIBITORS POSSESSING CLASSICAL AND TITLE 2 NON-CLASSICAL BIDENTATE SER212 INTERACTIONS. COMPND MOL_ID: 1; COMPND 2 MOLECULE: DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 62-393; COMPND 5 SYNONYM: MAP KINASE KINASE 1, MAPKK 1, MKK1, ERK ACTIVATOR KINASE 1, COMPND 6 MAPK/ERK KINASE 1, MEK 1; COMPND 7 EC: 2.7.12.2; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MAP2K1, MEK1, PRKMK1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: ROSETTA 2; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET24B KEYWDS KINASE, TRANSFERASE-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR R.HEALD,P.JACKSON,P.SAVY,M.JONES,E.GANCIA,B.BURTON,R.NEWMAN,J.BOGGS, AUTHOR 2 E.CHAN,J.CHAN,E.CHOO,M.MERCHANT,M.ULTSCH,C.WIESMANN,M.BELVIN,S.PRICE REVDAT 3 13-SEP-23 3V04 1 REMARK SEQADV LINK REVDAT 2 18-JUL-12 3V04 1 JRNL REVDAT 1 09-MAY-12 3V04 0 JRNL AUTH R.A.HEALD,P.JACKSON,P.SAVY,M.JONES,E.GANCIA,B.BURTON, JRNL AUTH 2 R.NEWMAN,J.BOGGS,E.CHAN,J.CHAN,E.CHOO,M.MERCHANT,P.RUDEWICZ, JRNL AUTH 3 M.ULTSCH,C.WIESMANN,Q.YUE,M.BELVIN,S.PRICE JRNL TITL DISCOVERY OF NOVEL ALLOSTERIC MITOGEN-ACTIVATED PROTEIN JRNL TITL 2 KINASE KINASE (MEK) 1,2 INHIBITORS POSSESSING BIDENTATE JRNL TITL 3 SER212 INTERACTIONS. JRNL REF J.MED.CHEM. V. 55 4594 2012 JRNL REFN ISSN 0022-2623 JRNL PMID 22506516 JRNL DOI 10.1021/JM2017094 REMARK 2 REMARK 2 RESOLUTION. 2.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0005 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 12908 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.213 REMARK 3 R VALUE (WORKING SET) : 0.212 REMARK 3 FREE R VALUE : 0.243 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.800 REMARK 3 FREE R VALUE TEST SET COUNT : 651 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 25 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.70 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.76 REMARK 3 REFLECTION IN BIN (WORKING SET) : 763 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 BIN R VALUE (WORKING SET) : 0.3040 REMARK 3 BIN FREE R VALUE SET COUNT : 30 REMARK 3 BIN FREE R VALUE : 0.2840 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2261 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 57 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 63.53 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 78.63 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.17000 REMARK 3 B22 (A**2) : 1.17000 REMARK 3 B33 (A**2) : -1.76000 REMARK 3 B12 (A**2) : 0.59000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.465 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.283 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.230 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 25.487 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.948 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.932 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2367 ; 0.007 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 2171 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3197 ; 1.049 ; 2.006 REMARK 3 BOND ANGLES OTHERS (DEGREES): 5077 ; 0.722 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 286 ; 5.551 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 97 ;32.779 ;24.433 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 425 ;14.462 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 12 ;15.355 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 348 ; 0.055 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2549 ; 0.002 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 441 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 458 ; 0.179 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 2367 ; 0.199 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1115 ; 0.174 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 1244 ; 0.081 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 27 ; 0.143 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): 1 ; 0.024 ; 0.200 REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 9 ; 0.521 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 39 ; 0.214 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 1 ; 0.018 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1446 ; 1.651 ; 2.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 586 ; 0.191 ; 2.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2318 ; 2.838 ; 5.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1011 ; 1.405 ; 2.500 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 879 ; 2.454 ; 5.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 501 A 503 REMARK 3 RESIDUE RANGE : A 61 A 382 REMARK 3 ORIGIN FOR THE GROUP (A): 30.3291 -21.3648 -33.5696 REMARK 3 T TENSOR REMARK 3 T11: -0.0096 T22: -0.2849 REMARK 3 T33: -0.0372 T12: -0.1586 REMARK 3 T13: 0.0129 T23: 0.0022 REMARK 3 L TENSOR REMARK 3 L11: 1.2921 L22: 1.2405 REMARK 3 L33: 4.4496 L12: 0.0672 REMARK 3 L13: 0.8524 L23: 0.9141 REMARK 3 S TENSOR REMARK 3 S11: -0.2384 S12: -0.0733 S13: 0.4010 REMARK 3 S21: 0.2201 S22: -0.0284 S23: 0.1397 REMARK 3 S31: 0.1218 S32: -0.0227 S33: 0.2668 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3V04 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 11-JAN-12. REMARK 100 THE DEPOSITION ID IS D_1000069426. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-JUL-08 REMARK 200 TEMPERATURE (KELVIN) : 200 REMARK 200 PH : 7.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : SI 111 CHANNEL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 13612 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.700 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 5.300 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.06200 REMARK 200 FOR THE DATA SET : 22.8800 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1S9J REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 62.92 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.32 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 16-20 %W/V PEG8K, 0.1M HEPES, 250MM REMARK 280 NH4H2PO4, 1MM TCEP, PH 7.2, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 286K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 62 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 -X,-Y,Z REMARK 290 5555 Y,-X+Y,Z+2/3 REMARK 290 6555 X-Y,X,Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 86.20200 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 43.10100 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 86.20200 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 43.10100 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASN A 221 REMARK 465 SER A 222 REMARK 465 PHE A 223 REMARK 465 GLY A 276 REMARK 465 CYS A 277 REMARK 465 GLN A 278 REMARK 465 VAL A 279 REMARK 465 GLU A 280 REMARK 465 GLY A 281 REMARK 465 ASP A 282 REMARK 465 ALA A 283 REMARK 465 ALA A 284 REMARK 465 GLU A 285 REMARK 465 THR A 286 REMARK 465 PRO A 287 REMARK 465 PRO A 288 REMARK 465 ARG A 289 REMARK 465 PRO A 290 REMARK 465 ARG A 291 REMARK 465 THR A 292 REMARK 465 PRO A 293 REMARK 465 GLY A 294 REMARK 465 ARG A 295 REMARK 465 PRO A 296 REMARK 465 LEU A 297 REMARK 465 SER A 298 REMARK 465 SER A 299 REMARK 465 TYR A 300 REMARK 465 GLY A 301 REMARK 465 MET A 302 REMARK 465 ASP A 303 REMARK 465 SER A 304 REMARK 465 ARG A 305 REMARK 465 GLN A 383 REMARK 465 PRO A 384 REMARK 465 SER A 385 REMARK 465 THR A 386 REMARK 465 PRO A 387 REMARK 465 THR A 388 REMARK 465 HIS A 389 REMARK 465 ALA A 390 REMARK 465 ALA A 391 REMARK 465 GLY A 392 REMARK 465 VAL A 393 REMARK 465 LEU A 394 REMARK 465 GLU A 395 REMARK 465 HIS A 396 REMARK 465 HIS A 397 REMARK 465 HIS A 398 REMARK 465 HIS A 399 REMARK 465 HIS A 400 REMARK 465 HIS A 401 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 N VAL A 224 N VAL A 224 4545 1.87 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 67 CB - CG - OD2 ANGL. DEV. = 5.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 78 80.83 52.38 REMARK 500 SER A 135 -120.96 -103.69 REMARK 500 ARG A 189 -6.31 81.63 REMARK 500 ASP A 190 55.47 -158.28 REMARK 500 SER A 241 -137.70 -160.51 REMARK 500 LEU A 381 -73.52 -137.48 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A 503 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASN A 195 OD1 REMARK 620 2 ASP A 208 OD2 86.8 REMARK 620 3 ATP A 502 O2A 165.8 93.0 REMARK 620 4 ATP A 502 O1B 85.1 164.0 91.5 REMARK 620 N 1 2 3 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE V04 A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ATP A 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG A 503 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3V01 RELATED DB: PDB DBREF 3V04 A 62 393 UNP Q02750 MP2K1_HUMAN 62 393 SEQADV 3V04 MET A 61 UNP Q02750 EXPRESSION TAG SEQADV 3V04 LEU A 394 UNP Q02750 EXPRESSION TAG SEQADV 3V04 GLU A 395 UNP Q02750 EXPRESSION TAG SEQADV 3V04 HIS A 396 UNP Q02750 EXPRESSION TAG SEQADV 3V04 HIS A 397 UNP Q02750 EXPRESSION TAG SEQADV 3V04 HIS A 398 UNP Q02750 EXPRESSION TAG SEQADV 3V04 HIS A 399 UNP Q02750 EXPRESSION TAG SEQADV 3V04 HIS A 400 UNP Q02750 EXPRESSION TAG SEQADV 3V04 HIS A 401 UNP Q02750 EXPRESSION TAG SEQRES 1 A 341 MET GLU LEU LYS ASP ASP ASP PHE GLU LYS ILE SER GLU SEQRES 2 A 341 LEU GLY ALA GLY ASN GLY GLY VAL VAL PHE LYS VAL SER SEQRES 3 A 341 HIS LYS PRO SER GLY LEU VAL MET ALA ARG LYS LEU ILE SEQRES 4 A 341 HIS LEU GLU ILE LYS PRO ALA ILE ARG ASN GLN ILE ILE SEQRES 5 A 341 ARG GLU LEU GLN VAL LEU HIS GLU CYS ASN SER PRO TYR SEQRES 6 A 341 ILE VAL GLY PHE TYR GLY ALA PHE TYR SER ASP GLY GLU SEQRES 7 A 341 ILE SER ILE CYS MET GLU HIS MET ASP GLY GLY SER LEU SEQRES 8 A 341 ASP GLN VAL LEU LYS LYS ALA GLY ARG ILE PRO GLU GLN SEQRES 9 A 341 ILE LEU GLY LYS VAL SER ILE ALA VAL ILE LYS GLY LEU SEQRES 10 A 341 THR TYR LEU ARG GLU LYS HIS LYS ILE MET HIS ARG ASP SEQRES 11 A 341 VAL LYS PRO SER ASN ILE LEU VAL ASN SER ARG GLY GLU SEQRES 12 A 341 ILE LYS LEU CYS ASP PHE GLY VAL SER GLY GLN LEU ILE SEQRES 13 A 341 ASP SER MET ALA ASN SER PHE VAL GLY THR ARG SER TYR SEQRES 14 A 341 MET SER PRO GLU ARG LEU GLN GLY THR HIS TYR SER VAL SEQRES 15 A 341 GLN SER ASP ILE TRP SER MET GLY LEU SER LEU VAL GLU SEQRES 16 A 341 MET ALA VAL GLY ARG TYR PRO ILE PRO PRO PRO ASP ALA SEQRES 17 A 341 LYS GLU LEU GLU LEU MET PHE GLY CYS GLN VAL GLU GLY SEQRES 18 A 341 ASP ALA ALA GLU THR PRO PRO ARG PRO ARG THR PRO GLY SEQRES 19 A 341 ARG PRO LEU SER SER TYR GLY MET ASP SER ARG PRO PRO SEQRES 20 A 341 MET ALA ILE PHE GLU LEU LEU ASP TYR ILE VAL ASN GLU SEQRES 21 A 341 PRO PRO PRO LYS LEU PRO SER GLY VAL PHE SER LEU GLU SEQRES 22 A 341 PHE GLN ASP PHE VAL ASN LYS CYS LEU ILE LYS ASN PRO SEQRES 23 A 341 ALA GLU ARG ALA ASP LEU LYS GLN LEU MET VAL HIS ALA SEQRES 24 A 341 PHE ILE LYS ARG SER ASP ALA GLU GLU VAL ASP PHE ALA SEQRES 25 A 341 GLY TRP LEU CYS SER THR ILE GLY LEU ASN GLN PRO SER SEQRES 26 A 341 THR PRO THR HIS ALA ALA GLY VAL LEU GLU HIS HIS HIS SEQRES 27 A 341 HIS HIS HIS HET V04 A 501 25 HET ATP A 502 31 HET MG A 503 1 HETNAM V04 4-[(2-FLUORO-4-IODOPHENYL)AMINO]-N-(2-HYDROXYETHOXY)- HETNAM 2 V04 1H-INDAZOLE-5-CARBOXAMIDE HETNAM ATP ADENOSINE-5'-TRIPHOSPHATE HETNAM MG MAGNESIUM ION FORMUL 2 V04 C16 H14 F I N4 O3 FORMUL 3 ATP C10 H16 N5 O13 P3 FORMUL 4 MG MG 2+ HELIX 1 1 LYS A 64 ASP A 66 5 3 HELIX 2 2 ALA A 106 GLN A 116 1 11 HELIX 3 3 VAL A 117 CYS A 121 5 5 HELIX 4 4 LEU A 151 GLY A 159 1 9 HELIX 5 5 PRO A 162 LYS A 185 1 24 HELIX 6 6 LYS A 192 SER A 194 5 3 HELIX 7 7 SER A 212 MET A 219 1 8 HELIX 8 8 SER A 231 GLY A 237 1 7 HELIX 9 9 VAL A 242 GLY A 259 1 18 HELIX 10 10 ASP A 267 PHE A 275 1 9 HELIX 11 11 ALA A 309 GLU A 320 1 12 HELIX 12 12 SER A 331 LEU A 342 1 12 HELIX 13 13 ASP A 351 VAL A 357 1 7 HELIX 14 14 HIS A 358 GLU A 367 1 10 HELIX 15 15 ASP A 370 GLY A 380 1 11 SHEET 1 A 5 PHE A 68 ALA A 76 0 SHEET 2 A 5 VAL A 81 HIS A 87 -1 O LYS A 84 N ILE A 71 SHEET 3 A 5 VAL A 93 HIS A 100 -1 O ARG A 96 N PHE A 83 SHEET 4 A 5 GLU A 138 GLU A 144 -1 O MET A 143 N ALA A 95 SHEET 5 A 5 PHE A 129 TYR A 134 -1 N PHE A 133 O SER A 140 SHEET 1 B 3 GLY A 149 SER A 150 0 SHEET 2 B 3 ILE A 196 VAL A 198 -1 O VAL A 198 N GLY A 149 SHEET 3 B 3 ILE A 204 LEU A 206 -1 O LYS A 205 N LEU A 197 LINK OD1 ASN A 195 MG MG A 503 1555 1555 2.22 LINK OD2 ASP A 208 MG MG A 503 1555 1555 1.97 LINK O2A ATP A 502 MG MG A 503 1555 1555 2.03 LINK O1B ATP A 502 MG MG A 503 1555 1555 2.27 CISPEP 1 ILE A 263 PRO A 264 0 2.41 SITE 1 AC1 15 GLY A 77 ASN A 78 GLY A 80 LYS A 97 SITE 2 AC1 15 LEU A 115 VAL A 127 ILE A 141 ASP A 208 SITE 3 AC1 15 PHE A 209 GLY A 210 VAL A 211 SER A 212 SITE 4 AC1 15 LEU A 215 MET A 219 ATP A 502 SITE 1 AC2 20 ALA A 76 GLY A 77 ASN A 78 GLY A 80 SITE 2 AC2 20 VAL A 82 ALA A 95 LYS A 97 MET A 143 SITE 3 AC2 20 GLU A 144 MET A 146 SER A 150 ASP A 152 SITE 4 AC2 20 GLN A 153 LYS A 192 SER A 194 ASN A 195 SITE 5 AC2 20 LEU A 197 ASP A 208 V04 A 501 MG A 503 SITE 1 AC3 4 LYS A 97 ASN A 195 ASP A 208 ATP A 502 CRYST1 82.113 82.113 129.303 90.00 90.00 120.00 P 62 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012178 0.007031 0.000000 0.00000 SCALE2 0.000000 0.014062 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007734 0.00000